Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atreca Inc Cl A
(NQ:
BCEL
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atreca Inc Cl A
< Previous
1
2
3
4
5
6
Next >
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
September 21, 2023
From
Atreca, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
August 14, 2023
Via
Benzinga
Analyst Expectations for Atreca's Future
June 05, 2023
Via
Benzinga
Recap: Atreca Q1 Earnings
May 10, 2023
Via
Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 11, 2023
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
12 Health Care Stocks Moving In Friday's Intraday Session
August 11, 2023
Via
Benzinga
The Latest Analyst Ratings for Atreca
March 30, 2023
Via
Benzinga
Preview: Atreca's Earnings
March 28, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
August 11, 2023
Via
Benzinga
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
August 10, 2023
From
Atreca, Inc.
Via
GlobeNewswire
3 Penny Stocks to Catapult You Into the Millionaires’ Club
July 13, 2023
These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up!
Via
InvestorPlace
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 21, 2023
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 21, 2023
Via
Benzinga
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting
June 05, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
May 10, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
April 26, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 13, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
March 30, 2023
Via
Benzinga
Philip Morris To Rally Over 22%? Here Are 10 Other Analyst Forecasts For Thursday
March 30, 2023
Chardan Capital cut the price target for Synlogic, Inc. (NASDAQ: SYBX) from $7 to $5.5. Chardan Capital analyst Keay Nakae maintained a Buy rating. Synlogic shares gained 2.9% to close at $0.63 on...
Via
Benzinga
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
March 29, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
March 23, 2023
Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the ongoing Phase 1b trial of ATRC-101
From
Atreca, Inc.
Via
GlobeNewswire
Atreca to Participate at Cowen’s 43rd Annual Health Care Conference
March 01, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Why Is T2 Biosystems (TTOO) Stock Down 21% Today?
February 14, 2023
T2 Biosystems (TTOO) stock is falling hard on Tuesday as investors react to a proposed public offering from the company.
Via
InvestorPlace
Why Is Atreca (BCEL) Stock Up Today?
February 14, 2023
Atreca (BCEL) stock is getting a boost on Tuesday as the biopharmaceutical company continues a recent rally connected to insider buying.
Via
InvestorPlace
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
February 14, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 14, 2023
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday!
Via
InvestorPlace
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
February 06, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Atreca Appoints Philippe Bishop, MD as Chief Medical Officer
January 09, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.